Trusted Press Release Distribution   Join | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Precision Business Insights
www.precisionbusinessinsights.com
Rajesh k
sales@precisionbusinessinsights.com
Precision Business Insights, Kemp House, 152 – 160 City Road,
EC1V 2NX

Bookmark and Share
U.S. Influenza Market | Competitive Intelligence 2013 to 2017 | Forecast 2018 to 2024
U.S. Influenza Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024


U.S. Influenza Market
BriefingWire.com, 6/13/2018 - U.S. Influenza Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

The U.S. Influenza market is growing at a significant CAGR due to rise in new born babies, and increase in geriatric population. Increase in vaccination awareness, favourable reimbursement scenario, and rising investment by companies in research and development activities are the major factors fuelling the growth of U.S. influenza market over the forecast period. The major market players have great pipeline products, initiatives by government bodies such as WHO and CDC to control and prevent influenza, technological advancements in diagnostic tests also fuel the growth of U.S. influenza market over the forecast period. However, limited production capacity, a high level of required investment, and stringent regulatory policies for new product approvals might hamper the growth of U.S. Influenza market.

A sample of this report is available upon request @

www.precisionbusinessinsights.com/market-reports/u-s-influenza-market/#ulp-4H8Z4LpNMLEuOnnx

The U.S. Influenza market is segmented on the basis of product type, distribution channel, and end user

Based on drug class, U.S. influenza market is segmented into the following:

• Anti-viral drugs

• Zanamivir

• Oseltamivir

• Amantadine

• Rimantadine

• Others

• Interferons

• Vaccines

• Trivalent

• Quadrivalent

To view TOC of this report is available upon request @

www.precisionbusinessinsights.com/market-reports/u-s-influenza-market/#ulp-c654SbFYO64MsOhu

Influenza vaccines are key revenue contributor for the growth of U.S. influenza market. The U.S. influenza market is in growing phase, several international players are actively involved in the development of vaccines and drugs to treat influenza. Launch of new products, technological innovations, and approvals from U.S. Food and Drug Administration (FDA) for various drugs might fuel the growth of U.S. influenza market. For instance, Sequires used both egg and cell-based technologies to offer the broadcast portfolio of influenza vaccines in the U.S. for both trivalent and quadrivalent formulations..

Need more information about this report @

www.precisionbusinessinsights.com/market-reports/u-s-influenza-market/#ulp-14mlyhjMGhVjZqa3

U.S. holds a dominant share in the global influenza market. The largest share is attributed to the higher rate of in-vitro diagnostics availability and technological advancements in medical devices which are primarily driving the U.S. Influenza market growth. As per CDC, persons above 6 months of age could be vaccinated to prevent the influenza infection. Increase in prevalence and incidence cases of influenza (According to CDC, about 5 to 20 percent of the U.S. people are infected with influenza in every year. CDC also states that about 200,000 people hospitalized and more than 36,000 people are dying from influenza in U.S) might increase the growth of U.S. influenza market.

Get access to full summary @

www.precisionbusinessinsights.com/market-reports/u-s-influenza-market/

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2013 Proserve Technology, Inc.